Microglia as mediators of inflammatory and degenerative diseases

Annual Review of Neuroscience

Volumn 22, Issue , 1999, Pages 219-240

  Gonzalez Scarano F ^a   Baltuch, Gordon ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Cytokines; Human immunodeficiency virus; Multiple sclerosis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY DISEASE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL LESION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; HIV INFECTIONS; HUMANS; INFLAMMATION; MICROGLIA; MULTIPLE SCLEROSIS; NERVE DEGENERATION;

EID: 0032942060     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.neuro.22.1.219     Document Type: Review

References (133)

1. Achim CL, Heyes MP, Wiley CA. 1993. Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J. Clin. Invest. 91:2769-75
2. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, et al. 1996. Immunologic NO synthase: elevation in severe AIDS dementia and induction by gp41. Science 274:1917-21
3. Akassoglou K, Probert L, Kontogoergos G, Kollias G. 1997. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158:438-45
4. Akiyama H, Ikeda K, Katoh M, et al. 1994. Expression of MRP14, 27E10, interferon-alpha and leukocyte common antigen by reactive microglia in postmortem human brain tissue. J. Neuroimmunol. 50:195-201
5. Akiyama H, McGeer PL. 1990. Brain microglia constitutively express beta-2 integrins. J. Neuroimmunol. 30:81-93
6. Akiyama H, Tooyama I, Kawamata T, et al. 1993. Morphological diversities of CD44 positive astrocytes in the cortex of normal subjects and patients with Alzheimer's disease. Brain Res. 632:249-59
7. Ard MD, Cole GM, Wei J, Mehrle AP, Fratkin JD. 1996. Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J. Neurosci. Res. 43:190-202
8. Bachwich PR, Censue SW, Larrick JW, Kunkel SL. 1986. Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. Biochem. Biophys. Res. Commun. 136:94-101
9. Bagasara O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Pomerantz RJ. 1996. Cellular reservoirs of HIV-1 in the central nervous system of infected-individuals: identification by the combination of in situ PCR and immunohistochemistry. AIDS 10:573-85
10. Banati RB, Gehrman J, Schubert P, Kreutzberg GW. 1993. Cytotoxicity of microglia. Glia 7:111-18
11. Banati RB, Hoppe D, Gottmann K, Kreutzberg GW, Kettenmann H. 1991. A subpopulation of bone marrow-derived macrophage-like cells shares a unique ion channel pattern with microglia. J. Neurosci. Res. 30:593-600
12. Barger SW, Harmon AD. 1997. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388:878-81
13. Barnum SR, Jones JL, Beneviste EN. 1993. Interleukin-1 and tumor necrosis factor-mediated regulation of C3 gene expression in human astroglioma cells. Glia 7:225-36
14. Berthiaume E, Medina C, Swanson J. 1995. Molecular size fractionation during endocytosis in macrophages. J. Cell Biol. 129:989-98
15. Bitting L, Naidu A, Cordell B, Murphy GM Jr. 1996. Beta-amyloid peptide secretion by a microglial cell line is induced by beta-amyloid-(25-35) and lipopolysaccharide. J. Biol. Chem. 271:16084-89
16. Bo L, Mork S, Kong PA, Nyland H, Pardo CA, Trapp BD. 1994. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J. Neuroimmunol. 51:135-46
17. Braak H, Braak E. 1994. Pathology of Alzheimer's disease. In Neurodegenerative Diseases, ed. DB Calne, pp. 585-613. Philadelphia: Saunders
18. Breitner JCS. 1996. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu. Rev. Med. 47:401-11
19. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, et al. 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335:639-42
20. Brew BJ, Rosenblum M, Cronin K, Price RW. 1995. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann. Neurol. 38:563-70
21. Brinkmann R, Schwinn A, Narayan O, Zink C, Kreth HW, et al. 1992. Human immunodeficiency virus infection in microglia: correlation between cells infected in the brain and cells cultured from infectious brain tissue. Ann. Neurol. 131:361-65
22. Chaudhry FA, Lehre KP, van Lookeren Campagne M, Ottersen OP, Danbolt NC, Storm-Mathisen J. 1995. Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15:711-20
23. Das S, Potter H. 1995. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 14:447-56
24. Davis JB, McMurray HF, Schubert D. 1992. The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem. Biophys. Res. Commun. 189:1096-100
25. Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, et al. 1992. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42:1736-39
26. del Rio Hortega P. 1932. Microglia. In Cytology and Cellular Pathology of the Nervous System, ed. W Penfield, pp. 482-534. New York: Hoeber
27. Demuis A, Sebben M, Haynes L, Pin J-P, Bockaert J. 1995. NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336:68-70
28. Dickson DW, Lee SC, Mattiace LA, et al. 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83
29. Diop AG, Lesort M, Esclaire F, Sindou P, Couratier P, Hugon J. 1994. Tetrodotoxin blocks HIV coat protein (gp120) toxicity in primary neuronal cultures. Neurosci. Lett. 165:187-90
30. Donnelly RJ, Friedhoff AJ, Beer B, et al. 1990. Interleukin-1 stimulates the beta-amyloid precursor protein promoter. Cell. Mol. Neurobiol. 10:485-95
31. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, et al. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the b-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-58
32. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-73
33. Eikelenboom P, Zhan SS, Kamphorst W, et al. 1994. Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's disease. Virchows Arch. 424:421-27
34. Epstein LG, Kuiken C, Blumberg BM, et al. 1991. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue specific evolution within host-determined quasispecies. Virology 180:583-90
35. Feng Y, Broder CC, Kennedy PE, Berger EA. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-77
36. Gabuzda DH, Ho DD, de la Monte SM, Hirsch MS, Rota TR, Sobel RA. 1986. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann. Neurol. 20:289-95
37. Gallo P, Piccinno MG, Krzalic L, Tavolato B. 1989. Tumor necrosis factor alpha (TNFα) and neurological diseases: failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumors. J. Immunol. 23:41-4
38. Gelbard HA, Dzenko KA, DiLoreto D, Del Cerro C, Del Cerro M, Epstein LG. 1993. Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev. Neurosci. 15:417-22
39. Gelbard HA, Nottet HSLM, Swindells S, Jett M, Dzenko KA, et al. 1994. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68:4628-35
40. Giulian D, Haverkamp LJ, Li J, et al. 1995. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem. Int. 27:119-37
41. Giulian D, Haverkamp LJ, Yu JH, et al. 1996. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16:6021-37
42. Giulian D, Wendt E, Vaca K, Noonan CA. 1993. The envelope glycoprotein of HIV-1 stimulates release of neurotoxins from monocytes. Proc. Natl. Acad. Sci. USA 90:2769-73
43. Glass JD, Fedor H, Wesselingh SL, McArthur JC. 1995. Immunocytochemical quantitation of Human Immunodeficiency Virus in the brain: correlations with dementia. Ann. Neurol. 38:755-62
44. Glass JD, Wesselingh SL, Selnes OA, McArthur JC. 1993. Clinical-neuropathological correlation in HIV-associated dementia. Neurology 43:2230-37
45. Goedert M, Spillantini MG, Hasegawa R, Jakes R, Crowther RA, Klug A. 1996. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease. Cold Spring Harbor Symp. Quant. Biol. 61:565-73
46. Green SP, Philips WA. 1994. Activation of the macrophages respiratory burst by phorbol myristate acetate: evidence for both tyrosine-kinase-dependent and independent pathways. Biochim. Biophys. Acta 1222:241-48
47. Griffin DE, Wesselingh SL, McCarthur JC. 1994. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 35:592-97
48. Griffin WS, Sheng JG, Roberts GW, Mrak RE. 1995. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54:276-81
49. He J, Chen Y, Farzan M, Choe H, Ohagen A, et al. 1997. CCR3 and CCR5 are coreceptors for HIV-1 infection of microglia. Nature 385:645-49
50. Hickey WF, Vass K, Lassmann H. 1992. Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J. Neuropathol. Exp. Neurol. 51:246-56
51. Hickey WF, Williams KC. 1998. Mononuclear phagocyte heterogeneity and the blood brain barrier: a model for HIV-1 neuropathogenesis. In The Neurology of AIDS, ed. HE Gendelman, SA Lipton, L Epstein, S Swindells, pp. 61-72. New York: Chapman & Hall
52. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV infection. Nature 373:123-26
53. Hughes ES, Bell JE, Simmonds P. 1997. Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes. J. Virol. 71:1272-80
54. Ilschner S, Ohlemeyer C, Gimpl G, Kettenmann H. 1995. Modulation of potassium currents in cultured murine microglial cells by receptor activation and intracellular pathways. Neuroscience 66:983-1000
55. Iqbal K, Grundke-Iqbal I. 1994. Neurofibrillary tangles. In Neurodegenerative Diseases, ed. DB Calne, pp. 71-81. Philadelphia: Saunders
56. Johnson RT, Glass JD, McArthur JC, Chesebro BW. 1996. Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with AIDS. Ann. Neurol. 39:392-95
57. Jordan CA, Watkins BA, Kufta C, Dubois-Dalcq M. 1991. Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. J. Virol. 65:736-42
58. Jordan EK, Heyes MP. 1993. Virus isolation and quinolonic acid in primary and chronic simian immunodeficiency virus infection. AIDS 7:1173-79
59. Kalaria RN, Perry G. 1993. Amyloid P component and other acute-phase proteins associated with cerebellar A beta deposits in Alzheimer's disease. Brain Res. 631:151-55
60. Kettenmann H, Hoppe D, Gottmann K, Banati R, Kreutzberg G. 1990. Cultured microglial cells have a distinct pattern of membrane channels different from peritoneal macrophages. J. Neurosci. Res. 26:278-87
61. Kimura-Kuroda J, Nagashima K, Yasui K. 1994. Inhibition of myelin formation by HIV-1 gp120 in rat cerebral cortex culture. Arch. Virol. 137:81-99
62. Klegeris A, Walker DG, McGeer PL. 1994. Activation of macrophages by Alzheimer beta amyloid peptide. Biochem. Biophys. Res. Commun. 199:984-91
63. Kolson DL, Buchhalter J, Collman R, Hellmig B, Farrell CF, et al. 1993. HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. AIDS Res. Hum. Retroviruses 9:677-85
64. Kondo K, Hashimoto H, Kitanaka J, Sawada M, Suzumura A, et al. 1995. Expression of glutamate transporters in cultured glial cells. Neurosci. Lett. 188:140-42
65. Korotzer AR, Watt J, Cribbs D, Tenner AJ, Burcick D, et al. 1995. Cultured rat microglia express C1q and receptor for C1q: implications for amyloid effects on microglia. Exp. Neurol. 13:214-21
66. Lane JH, Sasseville VG, Smith MO, Vogel P, Pauley DR, et al. 1997. Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation. J. Neurovirol. 6:423-32
67. Lane TE, Buchmeier MJ, Watry DD, Jakubowski DB, Fox HS. 1995. Serial passage of microglial SIV results in selection of homogenous env quasispecies in the brain. Virology 212:458-65
68. Lassman H, Zimprich F, Vass K, Hickey WF. 1993. Bone marrow derived elements and resident microglia in brain inflammation. Glia 7:19-24
69. Lavi E, Strizki JM, Ulrich AM, Zhang W, Fu L, et al. 1997. CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1) is expressed in the human brain in a variety of cell types including microglia and neurons. Am. J. Pathol. 151:1035-42
70. Lees GJ. 1993. Nitric oxide is produced by microglia. J. Neurol. Sci. 114:119-22
71. Li M, Sunamoto M, Ohnishi K, Ichimori Y. 1996. Beta-amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res. 720:93-100
72. Lipton SA. 1996. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species. Brain Pathol. 6:507-17
73. Liu J, Zhao ML, Brosnan CF, Lee SC. 1996. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1 beta and IL-1 receptor antagonist. J. Immunol. 157:3569-76
74. Lue L-F, Rogers J. 1992. Full complement activation fails in diffuse plaques of the Alzheimer's disease cerebellum. Dementia 3:308-13
75. Mankowski JL, Spelman JP, Ressetar HG, Strandberg JD, Laterra J, et al. 1994. Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J. Virol. 68:8202-8
76. Martin A, Heyes MP, Salazar AM, Kampen DL, Williams J, et al. 1992. Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. J. Neuropsych. Clin. Neurosci. 4:270-79
77. Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA. 1992. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab. Invest. 66:285-91
78. Masliah E, Mallory M, Hansen L, et al. 1991. Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in disease. Acta Neuropathol. Berlin 83:12-20
79. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE. 1993. Evidence of excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 10:243-54
80. McArthur JC, Selnes OA, Glass JD, Hoover DR, Bacellar H. 1994. In HIV, AIDS and the Brain, ed. RW Price, SW Perry, pp. 251-72. New York: Raven
81. McDonald DR, Brunden KR, Landreth GE. 1997. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 17:2284-94
82. McGeer PL, Itagaki S, Tago S, McGeer EG. 1987. Reactive microglia in patients with senile dementia of Alzheimer's type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79:1285-91
83. McGeer PL, Schulzer M, McGeer EG. 1996. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47:425-32
84. Meda L, Cassatella MA, Szendrei GI, et al. 1995. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374:647-50
85. Muller-Ladner U, Jones JL, Wetsel RA, Gay S, Raine CS, Barnum SR. 1996. Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J. Neurol. Sci. 144:135-41
86. Murphy T, Parikh A, Schnaar R, Coyle J. 1989. Arachidonic acid metabolism in glutamate neurotoxicity. Ann. N. Y. Acad. Sci. 559:474-75
87. Nuovo GJ, Alfieri ML. 1996. AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol. Med. 2:358-66
88. Nuovo GJ, Gallery F, MacConnell P, Braun A. 1994. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis-a RNA in the central nervous system. Am. J. Pathol. 144:659-66
89. Paresce DM, Chung H, Maxfield FR. 1997. Slow degradation of aggregates of the Alzheimer's disease amyloid β-protein by microglial cells. J. Biol. Chem. 272:29390-97
90. Paresce DM, Ghosh R, Maxfield FR. 1996. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17:553-65
91. Peress NS, Fleit HB, Perillo E, et al. 1993. Identification of Fc gamma RI, II, and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease. J. Neuroimmunol. 48:71-79
92. Perlmutter LS, Scott SA, Barron E, Chui HC. 1992. MHC classII-positive microglia in human brain: association with Alzheimer's lesions. J. Neurosci. Res. 33:549-58
93. Perrella O, Carrieri PB, Guarnaccia D, Soscia M. 1992. Cerebrospinal fluid cytokines and AIDS dementia complex. J. Neurol. 239:387-88
94. Peudenier S, Hery C, Ng KH, Tardieu M. 1991. HIV receptors within the brain: a study of CD4 and MHC-II on human neurons, astrocytes and microglial cells. Res. Virol. 142:145-49
95. Pietraforte D, Tritarelli E, Testa U, Minetti M. 1994. gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J Leukoc. Biol. 55:175-82
96. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, et al. 1994. Demented and nondemented patients with AIDS differ in brain-derived HIV-1 envelope sequences. J. Virol. 68:4643-49
97. Prineas JW. 1996. Pathology of multiple sclerosis. In Handbook of Multiple Sclerosis, ed. SE Cook, pp. 223-55. Monticello, NY: Dekker
98. Qiu WQ, Ye Z, Kholodenko D, Seubert P, Selkoe DJ. 1997. Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells. J Biol. Chem. 272:6641-46
99. Richardson A, Hao C, Fedoroff S. 1993. Microglia progenitor cells: a subpopulation in cultures of mouse neopallial glia. Glia 7:25-33
100. Rinner WA, Bauer J, Schmidts M, Lassmann H, Hickey WF. 1995. Resident microglia and hematogenous macrophages as phagocytes in adoptively transferred experimental autoimmune encephalomyelitis: an investigation using rat radiation bone marrow chimeras. Glia 14:257-66
101. Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, et al. 1992. Complement activation by b-amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 89:10016-20
102. Rogers J, Kirby LC, Hempelman SR, et al. 1993. Clinical trial of indomethacin in Alzheimer's disease. Neurology 43:1609-11
103. Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, Ringler DJ. 1997. Cellular localization of the chemokine receptor CCR5. Am. J. Pathol. 151:1341-51
104. Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, et al. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1193-1200
105. Sabatier JM, Vives E, Mabrouk K, Benjouad A, Rochat H, et al. 1991. Evidence for neurotoxic activity of tat from HIV-1. J. Virol. 65:961-67
106. Sasaki A, Yamaguchi H, Ogawa A, Sugihara S, Nakazato Y. 1997. Microglial activation in early stages of amyloid beta protein deposition. Acta Neuropathol. 94(4):316-22
107. Seilhean D, Kobayashi K, He Y, Uchihara T, Rosenblum O, et al. 1997. Tumor necrosis factor-alpha, microglia and astrocytes in AIDS dementia complex. Acta Neuropathol. 93:508-17
108. Selkoe DJ. 1996. Cell biology of the β-amyloid precursor protein and the genetics of Alzheimer's disease. Cold Spring Harbor Symp. Quant. Biol. 61:587-96
109. Sharer LR. 1992. Pathology of HIV-1 infection of the central nervous system: a review. J. Neuropath. Exp. Neurol. 51:3-11
110. Sharma DP, Anderson M, Zink MC, Adams R, Donnenberg AD, et al. 1992. Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytotropic parental virus: pathogenesis of infection in macaques. J. Virol. 66:3550-56
111. Sriram S, Rodriguez M. 1997. Indictment of the microglia as the villain in multiple sclerosis. Neurology 48:464-70
112. Stephens EB, Liu ZQ, Zhu GW, Adany I, Joag SV, et al. 1995. Lymphocyte-tropic SIV causes persistent infection in the brains of rhesus macaques. Virology 213:600-14
113. Strizki JM, Albright AV, Sheng H, O'Connor M, Perrin L, Gonzalez-Scarano F. 1996. Infection of primary human microglia and monocyte-derived macrophages with acute HIV-1 isolates: evidence of differential tropism. J. Virol. 70:7564-662
114. Tardieu M, Janabi N. 1994. HIV-1 and the developing human nervous system: in vivo and in vitro aspects. Dev. Neurosci. 16:137-44
115. Theele DP, Streit WJ. 1993. A chronicle of microglial ontogeny. Glia 7:5-8
116. Tienari PJ, DeStrooper B, Ikonen E, Ida N, Simons M, et al. 1996. Neuronal sorting and processing of amyloid precursor protein: implication for Alzheimer's disease. Cold Spring Harbor Symp. Quant. Biol. 61:575-85
117. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L. 1994. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188-93
118. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. 1998. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:278-85
119. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, et al. 1992. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:349-60
120. Ulvestad E, Williams K, Matre R, et al. 1994a. Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets. J. Neuropathol. Exp. Neurol. 53:27-36
121. Ulvestad E, Williams K, Vedeler C, Antel J, Nyland H, et al. 1994b. Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. J. Neurol. Sci. 121:125-31
122. Verbeek MM, Ruiter DJ, deWaal MW. 1997. The role of amyloid in the pathogenesis of Alzheimer's disease. Biol. Chem. 378:937-50
123. Waksman BH. 1959. Evidence favouring delayed sensitization as a mechanism underlying EAE. In Allergic Encephalitis, ed. M Kies, EC Alvord, pp. 419-43. Springfield, IL: Thomas
124. Wesselingh SL, Takahashi K, Glass JD, McArthur JC, Griffin JW, Griffin DE. 1997. Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. J. Neuroimmunol. 74:1-8
125. Westmoreland SV, Kolson D, Gonzalez-Scarano F. 1996. Toxicity of TNFα and platelet activating factor for human NT2N neurons: a tissue culture model for human immunodeficiency virus dementia. J. Neurovirol. 2:118-26
126. Westmoreland SV, Rottman JB, Williams KC, Lackner AA, Sasseville VG. 1998. Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis. Am. J. Pathol. 152:659-65
127. Wiley CA, Achim CA. 1994. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann. Neurol. 36:673-76
128. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA. 1986. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83:7089-93
129. Williams K, Bar-Or A, Ulvestad E, et al. 1992. Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J. Neuropathol. Exp. Neurol. 51:538-49
130. Wilt SG, Milward E, Zhou JM, Nagasato K, Patton H, et al. 1995. In vitro evidence for a dual role of tumor necrosis factor-a in human immunodeficiency virus type 1 encephalopathy. Ann. Neurol. 37:381-394.
131. Wisniewski T, Castano EM, Golabek A, et al. 1994. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145:1030-35
132. Yanker BA, Dawes LR, Fisher S, et al. 1989. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245:417-20
133. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. 1998. Function of the chemokine receptor CXCR4 in haematopoiesis and cerebellar development. Nature 393:595-99